Endonovo Therapeutics (ENDV) News Today $0.0004 0.00 (-33.33%) (As of 12/20/2024 05:55 PM ET) Add Compare Share Share Headlines Stock AnalysisChartFinancialsSEC FilingsShort Interest All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Endonovo Closes Asset Purchase Agreement for a Minimum of $50M With SofPulse, IncMarch 28, 2024 | globenewswire.comEndonovo’s SofPulse® to Be Featured at Innovative Pain Management SolutionsMarch 4, 2024 | finance.yahoo.comEndonovo's SofPulse® to Be Featured at Innovative Pain Management SolutionsMarch 4, 2024 | globenewswire.comEndonovo Signs Definitive Agreement to Sell SofPulse® Brand Business and IP to SofPulse Inc. for a minimum of $50 MillionDecember 4, 2023 | finance.yahoo.comEndonovo Therapeutics, Inc. (ENDV)November 21, 2023 | finance.yahoo.comLexeo Therapeutics Inc (LXEO)November 15, 2023 | investing.comEndonovo receives Taiwanese approval for SofPulse technologyOctober 13, 2023 | msn.comEndonovo's SofPulse® Secures Taiwan FDA ApprovalOctober 12, 2023 | finance.yahoo.comEndonovo’s SofPulse® Secures Federal Supply Schedule Inclusion to Accelerate Expansion of VA DistributionAugust 22, 2023 | finance.yahoo.comEndonovo’s Breaking Barriers in With Patented Medical Technologies: 2023 Bi-Annual UpdateAugust 8, 2023 | finance.yahoo.comNew to The Street TV Signs 6 Part Series, Featuring Endonovo Therapeutics, Inc.June 22, 2023 | finance.yahoo.comNew to The Street TV Signs 6 Part Series, Featuring Endonovo Therapeutics, Inc.June 22, 2023 | finance.yahoo.comEndonovo Pending Agreement to Develop Telehealth DivisionJune 7, 2023 | finance.yahoo.comEndonovo Launches SofPulse® into the Veterans AdministrationMay 2, 2023 | finance.yahoo.comEndonovo Reaches Out to Top Clinical Researchers to Collaborate on TBI Treatment StudiesApril 25, 2023 | finance.yahoo.comEndonovo Announces Partnership with Former NFL Dallas Cowboy Defensive LinemanApril 13, 2023 | finance.yahoo.comEndonovo Announces Partnership with Santana Lead Singer Andy VargasApril 10, 2023 | finance.yahoo.comEndonovo Announces Binding Letter of Intent to Sell SofPulse® Assets to Spin-Off CompanyMarch 29, 2023 | finance.yahoo.comEndonovo’s SofPulse® Nears Final Stages to Receive Taiwan FDA License to Distribute in TaiwanMarch 23, 2023 | finance.yahoo.comOlympian and Champion Surfer Carlos Muñoz Turns To SofPulse® For Accelerated Recovery After Invasive Shoulder SurgeryMarch 15, 2023 | finance.yahoo.comEndonovo Therapeutics (OTCMKTS:ENDV) Reaches Distribution Agreement with Academy MedicalMarch 9, 2023 | finance.yahoo.comEndonovo Announces Distribution Agreement with Academy MedicalMarch 6, 2023 | finance.yahoo.comEndonovo Announces Q&A with Newly-Appointed SofPulse® Medical Division President, Ira WeisbergFebruary 28, 2023 | finance.yahoo.comEndonovo Retains Ocean Tomo, a Part of J.S. Held, to Provide Fairness Opinion Analysis for Medical Device Spin-OffJanuary 31, 2023 | finance.yahoo.comEndonovo Partners with International Distributor for SofPulse® LineJanuary 26, 2023 | finance.yahoo.comENDV.PK - | Stock Price & Latest News | ReutersJanuary 23, 2023 | reuters.comNew Details on Endonovo’s Spin-Off of SofPulse, Inc.January 19, 2023 | finance.yahoo.comEndonovo Therapeutics Details Plan to Spin Off Medical Device Division as a Listed Public CompanyJanuary 9, 2023 | finance.yahoo.comEndonovo Targets Dept. of Defense, VA & Federal ContractsJanuary 3, 2023 | finance.yahoo.comEndonovo Announces Advancement of International “Go to Market” InitiativeDecember 19, 2022 | finance.yahoo.comEndonovo Announces Plans for Spin-off of Medical IP and AssetsDecember 15, 2022 | finance.yahoo.comEndonovo Launches Telehealth InitiativeDecember 13, 2022 | finance.yahoo.comEQS-News: Vivoryon Therapeutics N.V.: Vivoryon Therapeutics N.V. Reports Third Quarter 2022 Financial Results and Highlights Operational ProgressNovember 22, 2022 | markets.businessinsider.comENDONOVO ANNOUNCES PLAN TO EXPLORE STRATEGIC ALTERNATIVES FOR ITS SOFPULSE® MEDICAL DEVICE ASSETSNovember 17, 2022 | finance.yahoo.comEndonovo Therapeutics Issues Corporate UpdateNovember 7, 2022 | finance.yahoo.comAcrivon Therapeutics sets IPO price rangeNovember 3, 2022 | msn.comEQS-News: Vivoryon Therapeutics N.V.: Vivoryon Therapeutics N.V. Reports H1 2022 Financial Results and Highlights Operational ProgressSeptember 30, 2022 | markets.businessinsider.comEndonovo Therapeutics Signs Definitive Asset Purchase Agreement to Acquire A Highly Profitable Texas Concrete Construction CompanySeptember 27, 2022 | finance.yahoo.comEndonovo Therapeutics Releases Comparative Analysis DemonstratingJuly 28, 2022 | finance.yahoo.comStranger Things season 4 could have been even longer without the pandemicJuly 23, 2022 | yahoo.comDiagnostics Demystified By New "It’s Not Magic, It’s Diagnostics" CampaignJuly 23, 2022 | nz.finance.yahoo.comEndonovo Therapeutics Releases A Comparative Analysis Addressing Limitations Of Non-Opioid Pharmaceutical Interventions on the Reduction of Opioid/Narcotic Use For Post-Surgical Pain ManagementJuly 21, 2022 | finance.yahoo.comEndonovo Therapeutics Announces LOI to Acquire Specialty Construction CompanyJune 9, 2022 | finance.yahoo.comEndonovo Therapeutics Signs Agreement with NAMSA to Develop Reimbursement Strategy for Endonovo Medical ProductsApril 25, 2022 | finance.yahoo.com$5 Million Common Stock Offering for Endonovo Therapeutics Designed to Advance SofPulse® Process for Medical ReimbursementApril 11, 2022 | finance.yahoo.comEndonovo Therapeutics Inc ENDVMarch 3, 2022 | morningstar.comEndonovo Therapeutics Inc. (ENDV) Appoints Garry Michael Kann As Head of Corporate Development To Identify And Acquire Profitable Companies For EndonovoMarch 1, 2022 | finance.yahoo.comVerity Pharmaceuticals™ and Helsinn Therapeutics sign exclusive agreement for the promotion of Akynzeo® and Valchlor® in Puerto RicoFebruary 17, 2022 | benzinga.comEndonovo Therapeutics Issues Shareholder UpdateOctober 12, 2021 | finance.yahoo.com Get Endonovo Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ENDV and its competitors with MarketBeat's FREE daily newsletter. Email Address URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen. Register for the FREE Workshop Now & get $10 in Bitcoin ENDV Media Mentions By Week ENDV Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ENDV News Sentiment▼0.000.60▲Average Medical News Sentiment ENDV News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ENDV Articles This Week▼01▲ENDV Articles Average Week Get Endonovo Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ENDV and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies DYNT News Today UMGP News Today BIOL News Today IONM News Today BRSH News Today MOTS News Today ABMT News Today DRTSW News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:ENDV) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Endonovo Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Endonovo Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
